Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Sarcoma × Aminolevulinic Acid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Sarcoma 1 Neuroectodermal Tumors 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Neoplasm, Residual 1 Kidney Neoplasms 1 Glioma 1 Central Nervous System Neoplasms 1

Interventions

Doxorubicin 4 anlotinib 2 Injections 2 toripalimab 1 perflutren 1 pemigatinib 1 pazopanib 1 montelukast 1 liposomal doxorubicin 1 eribulin 1 chlorhexidine gluconate 1 camrelizumab 1 bexmarilimab 1 apatinib 1 X-Rays 1 Trabectedin 1 Tablets 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Ocoxin 1 Nivolumab 1 Negative-Pressure Wound Therapy 1 KP 1339 1 Ipilimumab 1 Immunotherapy 1 Ifosfamide 1 Heavy Ion Radiotherapy 1 Epirubicin 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡